JP Morgan Maintains Overweight on Septerna, Raises Price Target to $51

Benzinga · 1d ago
JP Morgan analyst Tessa Romero maintains Septerna (NASDAQ:SEPN) with a Overweight and raises the price target from $48 to $51.